DefinePK

DefinePK hosts the largest index of Pakistani journals, research articles, news headlines, and videos. It also offers chapter-level book search.

Ranibizumab: The Clinician?s Guide to Commencing, Continuing, and Discontinuing Treatment


Article Information

Title: Ranibizumab: The Clinician?s Guide to Commencing, Continuing, and Discontinuing Treatment

Authors: Qasim Lateef Chaudhry

Journal: Pakistan Journal of Ophthalmology

HEC Recognition History
Category From To
Y 2023-07-01 2024-09-30
Y 2022-07-01 2023-06-30
Y 2021-07-01 2022-06-30
Y 2020-07-01 2021-06-30

Publisher: ophthalmological society of Pakistan

Country: Pakistan

Year: 2008

Volume: 24

Issue: 2

Language: English

Categories

Abstract

The National Institute for Health and Clinical Excellence (NICE) Guidance has recommendded ranibizumab in the treatment of wet age related macular degeneration (AMD). The Institute further recommended that a national protocol specifying criteria for discontinuation of ranibizumab is developed. Criteria for discontinuation should include persistent deterioration in visual acuity and identifi-cation of anatomical changes in the retina that indicate inadequate response to therapy.
The Royal College of Ophthalmologists (RCOphth) recognised the need for such guidance and brought together a group of clinicians with expertise in the treatment of AMD with ranibizumab, NICE


Paper summary is not available for this article yet.

Loading PDF...

Loading Statistics...